American Oncology Institue, Hyderabad is thrilled to share the heartwarming story of a mother's selfless act to save her 13-year-old daughter from Thalassemia Major, treated by our Pediatric-Hemato -Oncologist and BMT Specialist, Dr C.S. Ranjith Kumar. #AOIHyderabad

Is there any strong evidence for post Allo HSCT intrathecal prophylaxis in ALL patient?Bipin Savani Prashant Mehta Naveen Pemmaraju, MD Venky Bone Marrow Transplantation RahulDoc Gaurav Narula MD Gaurav Prakash M.D.

Role of Giltertinib maintenance post HSCT in AML CR1? Phase III MORPHO Trial Post HSCT >30-60 day Bone marrow FLT3-ITD patient 120mg/day Giltertinib for 2 yrs >18yrs adults Benefit only in MRD + gp P value RFS 0.57

Adaptimmune’s Tecelra gains accelerated approval for synovial sarcoma pharmaceutical-technology.com/news/adaptimmu… via Pharma Technology Focus 1st FRA approved cell therapy in solid tumors ,pathbreaking.

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial - The Lancet Haematology thelancet.com/journals/lanha… How strong is the evidence

#EnemyofEconomy Siddaramaiah In a race to secure votes, Siddaramaiah’s “5 Guarantees” have crippled Karnataka’s economy. Free electricity under Gruha Jyothi, ₹2,000 per month for women under Gruha Lakshmi, free bus rides for women, and ₹3,000 for unemployed youth under Yuva

Letermovir prophylaxis in allo-HSCT with CMV+ IgG serology has become more accessible since the generic formulation became available, benefiting more patients. Continue HZV prophylaxis with Acivir and adjust Cyclosporin dosage as needed.

PARTIAL REPLACEMENT OF POST-TRANSPLANT CYCLOPHOSPHA... by Ranjith CS EHA Library; Jun 14 2025; 4161166 library.ehaweb.org/eha/2025/eha20…